Clinical Trial Update: Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mifepristone for glucose intolerance in obese/overweight adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Endo Crine Disease
• Glucose Intolerance

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Endocrine Disease, Diabetes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-14